Cargando…

COVID-19: geimpft, genesen oder erkrankt

Detalles Bibliográficos
Autor principal: Seufferlein, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806005/
http://dx.doi.org/10.1007/s12312-021-01033-9
_version_ 1784643350502047744
author Seufferlein, Thomas
author_facet Seufferlein, Thomas
author_sort Seufferlein, Thomas
collection PubMed
description
format Online
Article
Text
id pubmed-8806005
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-88060052022-02-02 COVID-19: geimpft, genesen oder erkrankt Seufferlein, Thomas Forum Präsident Springer Medizin 2022-02-01 2022 /pmc/articles/PMC8806005/ http://dx.doi.org/10.1007/s12312-021-01033-9 Text en © The Author(s), under exclusive licence to Deutsche Krebsgesellschaft e.V. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Präsident
Seufferlein, Thomas
COVID-19: geimpft, genesen oder erkrankt
title COVID-19: geimpft, genesen oder erkrankt
title_full COVID-19: geimpft, genesen oder erkrankt
title_fullStr COVID-19: geimpft, genesen oder erkrankt
title_full_unstemmed COVID-19: geimpft, genesen oder erkrankt
title_short COVID-19: geimpft, genesen oder erkrankt
title_sort covid-19: geimpft, genesen oder erkrankt
topic Präsident
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806005/
http://dx.doi.org/10.1007/s12312-021-01033-9
work_keys_str_mv AT seufferleinthomas covid19geimpftgenesenodererkrankt